Antibodies and methods used

The subject matter of the present disclosure provides antibodies that bind to KLB and FGFRl, as well as methods of use thereof. In certain embodiments, an antibody of this disclosure binds to an epitope present on FGFRl, and includes a bispecific antibody that binds to an epitope present on KLB. .FIELD 1A